Table 3 Comparison the ASR of Breast Cancer by Quality of Data Registration and period of the study in Eastern Mediterranean Region 1998–2019
Year | 1998–2000 | 2001–2005 | 2006–2010 | 2011–2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Data | N Data point | ASR of breast cancer | I2 Index | N Data point | ASR of breast cancer | I2 Index | N Data point | ASR of breast cancer | I2 Index | N Data point | ASR of breast cancer | I2 Index |
Total EMR | 42 | 23.04 (18.5,28.1) | 69.7 | 142 | 24.01 (20.2,27.04) | 70.7 | 219 | 26.01 (24.01,28.1) | 50.7 | 142 | 37.1(34.5, 39.8) | 44.8 |
Total EMR without Iran | 25 | 28.1 (20.3, 36) | 78 | 71 | 36.4 (31.4, 42.3) | 62.8 | 50 | 34.8 (31.4, 38.4) | 19.5 | 101 | 39.7 (36.03, 42.3) | 51.3 |
Group1: High Quality of Data | 8 | 18.5 (12.9,24.01) | 8.1 | 19 | 40.9 (31.4,51.8) | 14.7 | 17 | 34.8 (28.1,42.3) | 1 | 19 | 42.3 (32.5,51.8) | 1.2 |
Group2: Medium Quality of Data | 26 | 21.2 (16.8, 26.01) | 45.7 | 107 | 18.5 (16.1, 21.2) | 51.2 | 187 | 24.01 (22.1, 27.04) | 50.7 | 74 | 33.6 (30.3, 37.2) | 20.02 |
Group2: Medium Quality of Data without Iran | 9 | 30.3 (22.1, 40.9) | 44.3 | 36 | 28.1 (20.3, 36) | 0 | 18 | 36.4 (31.4, 42.3) | 21.1 | 32 | 34.8 (31.4, 38.4) | 27.9 |
Group2: Iran | 17 | 18.4 (13.7, 23.04) | 34.9 | 71 | 13.7 (11.6, 16.8) | 47.5 | 169 | 23.04 (18.5, 28.1) | 49.3 | 41 | 31.9 (28.2, 35.8) | 13.9 |
Group3: Low Quality of Data | 8 | 30.3 (13.7, 53.3) | 85.7 | 16 | 54.8 (37.2, 73.9) | 84.9 | 15 | 33.6 (30.3, 37.2) | 44.8 | 49 | 40.9 (34.8, 46.2) | 63.5 |